Case Comprehensive Cancer Center

Case CCC Population and Cancer Prevention Program member, Mohamed Draz, PhD, provided background information for a study published this week in MDLinx that indicates honey bees can detect certain cancers with nearly 90% accuracy. Draz explains, “Cancer metabolism produces specific compounds that…

A study with Case CCC's Population and Cancer Prevention Co-Leader Stephanie Schmit, PhD, MPH, as Principal Investigator aims to close the healthcare gap that disproportionately affects Hispanic/Latino (H/L) communities in the U.S. by identifying colorectal cancer screening (CRC) screening…

Case Comprehensive Cancer Center (Case CCC) and Cleveland Metroparks have partnered to make it easier for people to prevent skin cancer. Free sunscreen will be available to all visitors at participating Cleveland Metroparks beaches and golf courses.  The project, "Be Sun Smart. Protect Your Skin…

The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge. Despite the expectation that resistance-conferring mutations would dwindle in the absence of treatment due to a reduced growth rate, preexisting resistance is pervasive across diseases…

Reda Riffi, a first-generation student at Case Western Reserve University, was selected to participate in the BioMed Amgen Scholars Program at Yale University this summer. Riffi is majoring in neuroscience and conducts research at CWRU in the Xiong Lab. The BioMed Amgen Scholars Program is a…

With a new five-year, $2.78 million grant from the National Institutes of Health and National Cancer Institute, researchers at Case Western Reserve University (CWRU), Cleveland Clinic and University Hospitals (UH) will use artificial intelligence (AI) to better treat rectal cancer patients. The…

Nathan Berger with his wife, Sosamma J. Berger Nathan Berger arrived in Cleveland in 1983 with a vision: creating an oncology/hematology training program to position Case Western Reserve University School of Medicine as a leader in the burgeoning field of cancer care. The program he…

Eduarda Grinsztejn, MD, Case CCC Trainee Associate member, is one of nine individuals selected by the American Society of Hematology (ASH) for its 2024 ASH Minority Hematology Fellow Award (MHFA). This award encourages early-career researchers from historically underrepresented groups in the United…

An inter-organizational group of researchers and administrators from Case CCC recently published their work, "Impact of clinical trial design on recruitment of racial and ethnic minorities," in the Journal of Cancer Education. Case CCC affiliates include Population and Cancer Prevention Program…

The inaugural class of physician-scientists gathered with Case CCC leadership to celebrate the start of the Emerging Leaders Program (ELP)—an initiative aimed at developing leaders to take Case CCC to and beyond the half-century mark. The highly competitive selection process identified 10…